Date Filed | Type | Description |
03/15/2010 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/02/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
02/01/2010 |
EFFECT
| Form EFFECT - |
02/01/2010 |
EFFECT
| Form EFFECT - |
02/01/2010 |
EFFECT
| Form EFFECT - |
02/01/2010 |
EFFECT
| Form EFFECT - |
02/01/2010 |
EFFECT
| Form EFFECT - |
01/29/2010 |
4
| EVNIN LUKE (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns:
| Disposed/sold 4,814,725 shares
@ $0 |
|
01/29/2010 |
4
| MPM BIOVENTURES II QP LP (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns:
| Disposed/sold 4,814,725 shares
@ $0 |
|
01/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
01/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
01/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
01/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
01/28/2010 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
01/28/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
01/28/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
01/28/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
01/28/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
01/28/2010 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
01/28/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
01/28/2010 |
8-K
| Quarterly results |
01/27/2010 |
25-NSE
| Form 25-NSE - |
12/28/2009 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
12/17/2009 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
12/17/2009 |
425
| Form 425 - Prospectuses and communications, business combinations |
12/10/2009 |
SC 13G/A
| METABASIS THERAPEUTICS INC reports a 0% stake in Metabasis Therapeutics, Inc. |
12/02/2009 |
8-K
| Form 8-K - Current report |
12/02/2009 |
425
| Form 425 - Prospectuses and communications, business combinations |
11/19/2009 |
SC 13D
| METABASIS THERAPEUTICS INC reports a 33.2% stake in METABASIS THERAPEUTICS, INC. |
11/12/2009 |
10-Q
| Quarterly Report for the period ended September 30, 2009 |
11/10/2009 |
SC 13G/A
| METABASIS THERAPEUTICS INC reports a 5.1% stake in Metabasis Therapeutics, Inc. |
|